 best class consum stapl compani prior believ
strength brand improv process cultur chang set forth
past four year posit well even recessionari environ
immedi shock outbreak believ compani decis week
rais dividend time other find way preserv cash
clearli speak strength gs balanc sheet optim futur
busi perform even prior model forecast
rais organ sale growth estim
previous attempt captur stronger sale growth categori focu
market benefit pantri load well other benefit greater
stay-at-hom consumpt wed note nielsen scanner data show
 gs sale nearli wed previous trim estim reflect weaker
sale china total compani sale skii sale travel
retail though believ march gs suppli chain china could
competit advantag particularli tradit stapl categori like
guard soap profit assum stronger us dollar off-set greater
oper leverag given stronger sale growth full year rais ep
estim reflect ep growth lower
estim ep growth factor current fx spot rate
lap pantri load
lower usd
return equiti ttm
new price target reflect price-to-earnings multipl ep estim
assum pg trade premium large-cap stapl peer
previou price target reflect price-to-earnings multipl previou ep
estim assum pg trade premium peer
pg quarterli annual ep usd
idc link barclay live interact chart
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight year market share
declin believ better posit today
final grow ahead market expect stock
comfort hold rel premium versu
 consum stapl given above-p sale
assum trade upsid case ep
assum trade downsid ep
estim
organ sale growth impact consum stockpil
oper leverag benefit profit
degre brand abl continu grow categori gain
share recessionari environ
currenc modest neg impact fx off-set modest
posit impact
capital-expenditure sale
organ sale global market growth
ep mid high-singl digit
free cash flow product greater net earn
lauren lieberman herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
